Literature DB >> 1912738

High retention rates within a prospective study of heroin users.

M Desland1, R Batey.   

Abstract

The process of achieving a high retention rate of subjects in a 12-month prospective study of intravenous heroin users in Sydney, Australia is presented. Self-referred heroin users were compared with heroin users from a court diversion programme. The retention rates throughout the prospective study interview schedules were high, ranging from 69 to 83% of the original sample. No statistical differences were detected between the proportions located at each interview, indicating a high retention rate was maintained despite the passage of time. It is argued that contact with State services, i.e. Methadone Maintenance Programmes and the legal system, particularly the prison service, contributed to this high maintenance. It is speculated that the effectiveness of location strategies reflect prominent characteristics of the populations studied.

Entities:  

Mesh:

Year:  1991        PMID: 1912738     DOI: 10.1111/j.1360-0443.1991.tb01841.x

Source DB:  PubMed          Journal:  Br J Addict        ISSN: 0952-0481


  4 in total

1.  OPERATIONAL LESSONS FROM THE PATHWAYS TO DESISTANCE PROJECT.

Authors:  Carol A Schubert; Edward P Mulvey; Laurence Steinberg; Elizabeth Cauffman; Sandra H Losoya; Thomas Hecker; Laurie Chassin; George P Knight
Journal:  Youth Violence Juv Justice       Date:  2004-01-01

Review 2.  Methadone maintenance treatment: an update.

Authors:  G Bertschy
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

Review 3.  Systematic review identifies number of strategies important for retaining study participants.

Authors:  Karen A Robinson; Cheryl R Dennison; Dawn M Wayman; Peter J Pronovost; Dale M Needham
Journal:  J Clin Epidemiol       Date:  2007-05-10       Impact factor: 6.437

4.  Pathological findings of myocardium in a patient with cardiac conduction defect associated with an SCN5A mutation.

Authors:  Hiroaki Kawano; Koichi Kawamura; Masaki Kohno; Mitsuaki Ishijima; Satoki Fukae; Taisuke Ishikawa; Naomasa Makita; Koji Maemura
Journal:  Med Mol Morphol       Date:  2021-03-02       Impact factor: 2.309

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.